CLINICAL STAGE IV GASTRIC CANCER AJCC V8
Clinical trials for CLINICAL STAGE IV GASTRIC CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new CLINICAL STAGE IV GASTRIC CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for CLINICAL STAGE IV GASTRIC CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a stronger chemo cocktail extend life for stomach cancer patients?
Disease control Recruiting nowThis study compares two chemotherapy combinations for people with advanced stomach, esophageal, or gastroesophageal junction cancer that cannot be removed by surgery or has spread. About 382 participants will receive either the standard FOLFOX chemo (with or without the immunothe…
Matched conditions: CLINICAL STAGE IV GASTRIC CANCER AJCC V8
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 26, 2026 10:00 UTC
-
New drug combo shows promise in advanced stomach cancer trial
Disease control Recruiting nowThis study is for people with advanced stomach or esophageal cancer that has spread. It tests whether adding the immunotherapy drug nivolumab to the usual two-drug treatment (paclitaxel and ramucirumab) helps control the cancer longer. About 224 participants will be randomly assi…
Matched conditions: CLINICAL STAGE IV GASTRIC CANCER AJCC V8
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 09:58 UTC
-
Can switching PARP inhibitors outsmart cancer? new trial aims to find out
Disease control Recruiting nowThis study is testing a drug called talazoparib in people with advanced solid tumors that have specific DNA repair gene mutations. The goal is to see if this PARP inhibitor can shrink tumors or slow their growth, even in patients who have already tried a similar drug. About 36 ad…
Matched conditions: CLINICAL STAGE IV GASTRIC CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 09:58 UTC
-
New combo attack on stomach cancer shows early promise
Disease control Recruiting nowThis early-phase trial tests two drugs, pembrolizumab and lenvatinib, in about 15 people with advanced stomach or gastroesophageal cancer that has spread or can't be surgically removed. Pembrolizumab helps the immune system fight cancer, while lenvatinib blocks enzymes that help …
Matched conditions: CLINICAL STAGE IV GASTRIC CANCER AJCC V8
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 09:55 UTC
-
New drug duo targets hard-to-treat stomach cancers
Disease control Recruiting nowThis early-stage study tests two drugs together for people with HER2-positive stomach cancer or other solid tumors that have spread or can't be removed. The drugs, trastuzumab deruxtecan and azenosertib, aim to kill cancer cells more effectively. The main goals are to find the be…
Matched conditions: CLINICAL STAGE IV GASTRIC CANCER AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 09:55 UTC
-
Chemo mist trial aims to shrink abdominal tumors with fewer side effects
Disease control Recruiting nowThis early-phase trial is testing a procedure called PIPAC, which turns liquid chemotherapy into a fine mist and sprays it directly into the abdomen during a keyhole surgery. It is for people with ovarian, uterine, appendix, colorectal, or stomach cancer that has spread to the li…
Matched conditions: CLINICAL STAGE IV GASTRIC CANCER AJCC V8
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 26, 2026 09:52 UTC
-
Custom-Made cancer vaccine shows promise in advanced tumors
Disease control Recruiting nowThis study tests a personalized vaccine made from a patient's own tumor proteins, combined with the immunotherapy drug pembrolizumab, for people with advanced solid tumors (like breast, lung, or skin cancer). The goal is to see if the combination is safe and helps the immune syst…
Matched conditions: CLINICAL STAGE IV GASTRIC CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New hope for stomach cancer spread? drug combo trial opens at mayo clinic
Disease control Recruiting nowThis early-stage study tests whether adding a drug called aldesleukin (IL-2) to standard immunotherapy and chemotherapy can better control stomach cancer that has spread to the abdomen lining. About 15 adults with this condition will receive the combination. The goal is to see if…
Matched conditions: CLINICAL STAGE IV GASTRIC CANCER AJCC V8
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Scientists use live camera to peek inside tumors during surgery
Knowledge-focused Recruiting nowThis study uses a special microscope called intravital microscopy (IVM) to watch blood vessels inside solid tumors in real time during surgery. Researchers want to see how these vessels work, which could help decide if a patient's tumor is likely to respond to certain treatments.…
Matched conditions: CLINICAL STAGE IV GASTRIC CANCER AJCC V8
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 22, 2026 13:51 UTC